Literature DB >> 3025905

Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome.

M N Starkman, D E Schteingart, M A Schork.   

Abstract

Twenty-three patients with pituitary adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome were studied before and after treatment. The relationship between the amelioration of the depressive syndrome and changes in cortisol and ACTH levels was investigated. There was a significant difference in mean change in 24-hour urinary free cortisol (UFC) excretion for changes in the depressed mood score from first to last visit. There were also significant correlations between decreases in UFC and decreases in both the depressed mood score and the modified Hamilton depression score. These relationships were not found for ACTH. Furthermore, with cortisol decreased to normal levels, continued high ACTH levels did not prevent improvement in depressed mood. The possibility that cortisol may also play a role in the pathogenesis and/or maintenance of the mood disorder in psychiatric patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025905     DOI: 10.1016/0165-1781(86)90096-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  22 in total

Review 1.  Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis.

Authors:  Cheryl D Conrad
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

2.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

3.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5.

Authors:  Xiaoju Yang; Erin R Ewald; Yuqing Huo; Kellie L Tamashiro; Roberto Salvatori; Akira Sawa; Gary S Wand; Richard S Lee
Journal:  Biochem Biophys Res Commun       Date:  2012-03-16       Impact factor: 3.575

5.  Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure.

Authors:  Erin R Ewald; Gary S Wand; Fayaz Seifuddin; Xiaoju Yang; Kellie L Tamashiro; James B Potash; Peter Zandi; Richard S Lee
Journal:  Psychoneuroendocrinology       Date:  2014-03-20       Impact factor: 4.905

Review 6.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

Authors:  L H Price; R T Malison; C J McDougle; G H Pelton
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 8.  Environmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis.

Authors:  Richard S Lee; Akira Sawa
Journal:  Neuroendocrinology       Date:  2014-11-18       Impact factor: 4.914

Review 9.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

10.  Evaluation of depression, quality of life and body image in patients with Cushing's disease.

Authors:  Nilufer Alcalar; Sedat Ozkan; Pinar Kadioglu; Ozlem Celik; Penbe Cagatay; Baris Kucukyuruk; Nurperi Gazioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.